Basic Ordering Agreement 36C24219G0027

This Basic Ordering Agreement (BOA) represents a consignment agreement for stents awarded to Medtronic USA Inc. by Veterans Integrated Service Network 2 (VISN 2), a component of the Department of Veterans Affairs. The single-award contract was established on April 26, 2019, with an ultimate completion date of June 13, 2022, and carries a ceiling value of $0.00, indicating this agreement functions as a framework contract establishing terms and conditions for ordering rather than a committed financial obligation. The contract leverages Medtronic USA Inc.'s established position as a critical federal vendor specializing in advanced medical device technologies, including cardiovascular intervention equipment and surgical implants. As a foreign-owned, for-profit manufacturer headquartered in Minneapolis, Minnesota, Medtronic maintains current System for Award Management (SAM.gov) registration and holds a Unique Entity Identifier (UEI) of GPRGARK3K6L8. The VA's use of a consignment model for stents aligns with healthcare supply chain best practices, allowing Veterans Health Administration facilities within VISN 2 to maintain optimal inventory levels of these critical cardiovascular devices while managing procurement costs through tiered pricing established within the BOA framework.

Under this consignment arrangement, Medtronic provides stent inventory management and supply support to VISN 2 facilities, enabling rapid deployment of these essential cardiovascular devices for interventional procedures throughout the Veterans Integrated Service Network's geographic service area. The BOA structure establishes the baseline commercial terms, pricing, quality standards, and delivery requirements that govern subsequent task orders or purchase requests issued by VISN 2 medical centers. Medtronic's demonstrated federal contracting history across the Department of Veterans Affairs—including significant work with multiple Veterans Integrated Service Networks and the Defense Logistics Agency for cardiovascular devices, imaging systems, and surgical equipment—establishes the company's technical capability and reliability for this critical supply mission. The stent consignment agreement reflects the VA's strategic approach to ensuring veteran beneficiaries have timely access to life-saving cardiovascular interventional equipment while optimizing inventory turnover and procurement efficiency within the Veterans Health Administration supply chain.